Ionis Pharmaceuticals Inc
IONS· Nasdaq
Released Aug 5, 2020, during market hours
10-Q filed Aug 5, 2020, 36 days after period end · 0000874015-20-000115
| Metric | Q2 2020 | Q2 2019 | Q2 2018 | Q2 2017 |
|---|---|---|---|---|
| Revenue | $145.54M | $163.81M | $117.75M | $112.27M |
| Net Income | -$25.64M | -$876.00K | -$40.36M | -$3.09M |
| EPS Diluted |
Ionis Pharmaceuticals Inc · CIK 874015 · Engraved from SEC EDGAR
| -$0.18 |
| -$0.01 |
| -$0.29 |
| -$0.02 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.